Home Health Atrium Health receives $1 million donation to advance research at Levine Cancer Institute

Atrium Health receives $1 million donation to advance research at Levine Cancer Institute

Atrium Health receives $1 million donation to advance research at Levine Cancer Institute


CHARLOTTE — Atrium Health has announced that it has received a $1 million donation to further advance research at the Levine Cancer Institute.

The hospital said the donation will establish the Gayle J. and Charles C. Tallardy III Foundation Distinguished Chair in Clinical Research Endowment at Levine Cancer Institute.

“Transformational gifts such as these help position us among the best health systems in the country,” said Dr. Derek Raghavan, president of Levine Cancer Institute. “We are grateful to the Tallardy family for their generosity and for their commitment to advancing next-generation medicine.”

Gayle Tallardy, a native of Davidson, North Carolina, said the foundation was inspired by her lifelong interest in science and her family’s experiences with cancer.

Gayle said her father, Dr. Claude Hardison McConnell, battled melanoma. After his passing, the Tallardys said they were moved to support immunotherapy, an area of research that shows great potential in treating melanoma.

Gayle and Carl said they toured the translational research laboratory at Levine Cancer Institute and immediately saw an opportunity to meaningfully impact the trajectory of cancer care in the greater Charlotte region.

“We are honored to stand behind Levine Cancer Institute’s commitment to research, allowing clinicians to move beyond simply treating patients, to developing lifesaving cures,” Gayle Tallardy said.

Atrium Health said the Levine Cancer Institute is the first beneficiary of its kind to receive an endowed gift of this magnitude from the foundation in support of clinical research.

The endowment will help advance medical research leading to earlier detection, novel therapies, improved outcomes and curative treatments for melanoma through the Levine Cancer Institute’s Immuno-Oncology program. Immunotherapy, a form of biological therapy that uses an individual’s own immune system to fight cancer, allows researchers to create personalized therapies to better target the disease.

The first recipient of the chair, Associate Professor of Medicine and Research Group Director of Levine Cancer Institute’s Immune Monitoring Core Laboratory David M. Foureau, will be honored at a private ceremony next month.

Foureau is a 14-year veteran of Atrium Health and has earned a master’s degree in immunology at the Pasteur Institute in Paris and a doctorate in microbiology and immunology at Dartmouth College.

“Immunotherapy clinical trials for melanoma will help to advance the broader knowledge of how this form of therapy can impact different forms of cancer,” Foureau said.

Foureau spoke about the importance of the Tallardy’s gift to immunotherapy research, citing sarcoma, breast cancer, colorectal cancer, multiple myeloma and non-Hodgkin’s lymphoma as examples.

“This generous donation by Gayle and Carl Tallardy will help continue to drive the immunotherapy revolution,” Foureau said.

(WATCH BELOW: Atrium builds first full-service hospital in Charlotte area in decades)


Source link


Please enter your comment!
Please enter your name here